BCAS3
Basic information
Region (hg38): 17:60677453-61392838
Links
Phenotypes
GenCC
Source:
- Hengel-Maroofian-Schols syndrome (Strong), mode of inheritance: AR
- Hengel-Maroofian-Schols syndrome (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Hengel-Maroofian-Schols syndrome | AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Musculoskeletal; Neurologic; Ophthalmologic | 34022130 |
ClinVar
This is a list of variants' phenotypes submitted to
- Inborn_genetic_diseases (103 variants)
- Global_developmental_delay (12 variants)
- Hengel-Maroofian-Schols_syndrome (9 variants)
- not_provided (9 variants)
- BCAS3-related_disorder (2 variants)
- not_specified (2 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the BCAS3 gene is commonly pathogenic or not. These statistics are base on transcript: NM_000017679.5. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | |||||
| missense | 101 | 109 | ||||
| nonsense | 9 | |||||
| start loss | 0 | |||||
| frameshift | 2 | |||||
| splice donor/acceptor (+/-2bp) | 1 | |||||
| Total | 1 | 14 | 102 | 7 | 2 |
Highest pathogenic variant AF is 0.000024247489
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| BCAS3 | protein_coding | protein_coding | ENST00000390652 | 24 | 715386 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0.000138 | 1.00 | 124771 | 0 | 37 | 124808 | 0.000148 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.60 | 375 | 546 | 0.687 | 0.0000307 | 6050 |
| Missense in Polyphen | 153 | 224.41 | 0.68178 | 2416 | ||
| Synonymous | 0.226 | 192 | 196 | 0.979 | 0.0000114 | 1840 |
| Loss of Function | 4.80 | 18 | 57.2 | 0.315 | 0.00000358 | 574 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.000449 | 0.000449 |
| Ashkenazi Jewish | 0.000200 | 0.000199 |
| East Asian | 0.000167 | 0.000167 |
| Finnish | 0.000139 | 0.000139 |
| European (Non-Finnish) | 0.000107 | 0.000106 |
| Middle Eastern | 0.000167 | 0.000167 |
| South Asian | 0.0000988 | 0.0000980 |
| Other | 0.000165 | 0.000165 |
dbNSFP
Source:
- Function
- FUNCTION: Plays a role in angiogenesis. Participates in the regulation of cell polarity and directional endothelial cell migration by mediating both the activation and recruitment of CDC42 and the reorganization of the actin cytoskeleton at the cell leading edge. Promotes filipodia formation (By similarity). Functions synergistically with PELP1 as a transcriptional coactivator of estrogen receptor-responsive genes. Stimulates histone acetyltransferase activity. Binds to chromatin. {ECO:0000250|UniProtKB:Q8CCN5, ECO:0000269|PubMed:17505058}.;
- Disease
- DISEASE: Note=A chromosomal aberration involving BCAS3 has been found in some breast carcinoma cell lines. Translocation t(17;20)(q23;q13) with BCAS4.;
- Pathway
- Ectoderm Differentiation
(Consensus)
Intolerance Scores
- loftool
- 0.479
- rvis_EVS
- -0.75
- rvis_percentile_EVS
- 13.67
Haploinsufficiency Scores
- pHI
- 0.637
- hipred
- Y
- hipred_score
- 0.682
- ghis
- 0.537
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.948
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Bcas3
- Phenotype
- cellular phenotype; mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); growth/size/body region phenotype; cardiovascular system phenotype (the observable morphological and physiological characteristics of the mammalian heart, blood vessels, or circulatory system that are manifested through development and lifespan); embryo phenotype;
Gene ontology
- Biological process
- angiogenesis;Golgi organization;positive regulation of endothelial cell migration;microtubule organizing center organization;negative regulation of GTPase activity;tube formation;response to starvation;positive regulation of catalytic activity;positive regulation of GTPase activity;positive regulation of transcription by RNA polymerase II;positive regulation of filopodium assembly;negative regulation of focal adhesion assembly;cellular response to estrogen stimulus;positive regulation of intracellular protein transport;activation of GTPase activity;regulation of establishment of cell polarity;positive regulation of actin cytoskeleton reorganization
- Cellular component
- nucleus;nucleolus;cytoplasm;cytoplasmic microtubule;cell leading edge;transcriptionally active chromatin;intermediate filament cytoskeleton;cell periphery
- Molecular function
- chromatin binding;protein binding;transcription factor binding;acetyltransferase activator activity;histone acetyltransferase binding;nuclear hormone receptor binding;histone binding;beta-tubulin binding